Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy

European Journal of Epidemiology

Volumn 18, Issue 6, 2003, Pages 583-588

  Ansaldi, F ^a   Comar, M ^a   D'Agaro, P ^a   Grainfenberghi, S ^a   Caimi, L ^a   Gargiulo, F ^a   Bruzzone, B ^a   Gasparini, R ^a   Icardi, G ^a   Perandin, F ^a   Campello, C ^a   Manca, Nino ^b  

^a Spedali Civili ^*

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Human T cell leukemia virus type 1 and type 2; Immigrants; Prevalence; Risk factors

Indexed keywords

ADULT; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMIGRANT; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRISONER; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ADULT; ANTIBODIES, VIRAL; EMIGRATION AND IMMIGRATION; FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; ITALY; MALE; PRISONERS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0041302548     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024655228893     Document Type: Article

References (30)

1. Hino S, Yamaguchi K, Katamine S. Mother-to-child transmission of human T cell leukemia virus type-I. Jpn J Cancer Res 1985; 76: 474-480.
2. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother to child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1997; 1: 37-44.
3. Blattner WA. Human lymphotropic viruses: HTLV-I and HTLV-II. In: Richman DD, Whitley RJ, Hayden FG (eds), Clinical virology. New York: Churchill Livingstone, 1997; 683-705.
4. Tajima K. Worldwide distribution of HTLV. Jpn J Cancer Res 1998; 89: 16-20.
5. Lairmore MD, Jacobson S, Gracia F, et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi indians in Panama. Proc Natl Acad Sci USA 1990; 87: 8840-8844.
6. Froment A, Deleporte E, Dazza M, et al. HTLV-II among Pygmies from Cameroon. AIDS Res Human Retroviruses 1993; 9: 707.
7. Brennan M, Runganga J, Barbara JA, et al. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Br Med J 1994; 308: 273-279.
8. Dalekos GN, Zervou E, Karabini F, et al. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion 1995; 35: 503-506.
9. The HTLV European Research Network. Seroepidemiology of the human T-cell leukemia/lymphoma viruses in Europe. J Acquir Immuno Defic Syndr 1996; 13: 68-77.
10. Tosswill Jennifer HC, Taylor GP, et al. HTLV-I/II associated disease in England and Wales, 1993-7: Retrospective review of serology requests. Br Med J 2000; 320: 611-612.
11. Fanin R, Minutillo S, D'Agaro P, et al. HTLV-I positive adult T-cell leukemia-lymphoma: Report of a typical case from Italy. Haematologica 1990; 75: 375-380.
12. Chironna M, Quarto M, Specchia G, et al. Familiar clustering of HTLV-I infection in southeastern Italy. Lancet 1995; 346: 179-180.
13. Suligoi B, Galli C, Ciuta S, et al. Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Eur J Epidemiol 1999; 15: 225-229.
14. Giuliani M, Rezza G, Lepri AC, et al. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases. Sex Transm Dis 2000; 27: 87-92.
15. Kwok S, Ehrlich G, Poeisz B, et al. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988; 72: 1117-1123.
16. Ehrlich G, Greenberg S, Abbott M. Detection of human T-cell lymphoma-leukemia viruses. In: Innis MA, Gelfand DH, Sninskj JJ, Whitte TJ (eds), PCR Protocols, a Guide to Method and Application, Academic Press, 1990.
17. Department of the Interior. Report of immigration from emergency to programme. www.interno.it.
18. Vlahov D, Lee H, Taylor E, et al. Antibody to human T-lymphotropic virus I/II among male inmates entering Maryland prisons. J Acquir Immuno Defic Syndr 1990; 3: 531-535.
19. Manca N, Graifenberghi S, Colombrita D, et al. Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients. Eur J Epidemiol 1990; 6: 201-206.
20. Christensen PB, Krarup HB, Niesters HG, et al. Prevalence and incidence of bloodborn viral infections among Danish prisoners. Eur J Epidemiol 2000; 16: 1043-1049.
21. Larsen O, Andersson S, da Silva Z, et al. Prevalence of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquired Immuno Defic Syndr 2000; 25: 157-163.
22. Segurado AAC, Malaque CMS, Sumita LM, et al. Laboratory characterization of human T-cell lymphotopic viruses types 1 (HTLV-1) and 2 (HTLV-2) infection in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg 1997; 57: 142-148.
23. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951-1958.
24. Stephen EH, Foote K, Hendershot GE, et al. Health of the foreign-born population: United States, 1989-1990. Adv data 1994; 241: 1-12.
25. Trujillo JM, Concha M, Munoz, et al. Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia. J Acquir Immuno Defic Syndr Res Hum Retroviruses 1992; 8: 651-657.
26. Mueller N, Okayama A, Stuver S, et al. Finding from the Miyazaki cohort study. J Acquir Immuno Defic Syndr Hum Retrovirol 1996; 13: 2-7.
27. Catalan-Soarez BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, HBV, HCV, Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais States, Brazil. Rev Soc Bras Med Trop 2000; 33: 27-30.
28. Murphy EL. The clinical epidemiology of human T-lymphotropic virus type II (HTLV-II). J Acquir Immuno Defic Syndr Hum Retrovirol 1996; 13S: 215-219.
29. Lowis GW, Sheremata WA, Minagar A. Epidemiologic feature of HTLV-II. Serological and molecular evidence. Ann Epidemiol 2002; 12: 46-66.
30. Brites C, Harrington W, Pedroso C, et al. Epidemiological characteristics of HTLV-I and II co-infection in brazilian subjects infected by HIV-1. Braz J Infect 1997; 1: 42-47.